Reuters logo
BRIEF- GSK, MMV say Tafenoquine receives Breakthrough Therapy title from FDA
December 20, 2013 / 3:50 PM / 4 years ago

BRIEF- GSK, MMV say Tafenoquine receives Breakthrough Therapy title from FDA

Dec 20 (Reuters) - GlaxoSmithKline Plc : * Joint press release: GSK and mmv announce FDA breakthrough therapy designation for Tafenoquine for plasmodium vivax malaria * Tafenoquine is not yet approved or licensed for use anywhere in the world * Plans are underway to start a phase III study in 2014 * For more news, please click here

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below